US 12404505
Delivery of a gene-editing system with a single retroviral particle and methods of generation and use
granted A61KA61K48/0091
Quick answer
US patent 12404505 (Delivery of a gene-editing system with a single retroviral particle and methods of generation and use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K48/0091